Schizotrin A; a novel antimicrobial cyclic peptide from a cyanobacterium
A novel antimicrobial cyclic undecapeptide, schizotrin A, is the major active metabolite in the cultured cyanobacterium Schizotrix sp.
References (12)
J. Appl. Bacteriol.
(1992)- et al.
J. Org. Chem.
(1984) - et al.
J. Org. Chem.
(1988) - et al.
J. Am. Chem. Soc.
(1989) - et al.
J. Org. Chem.
(1992) - et al.
J. Antibiotics
(1992)
There are more references available in the full text version of this article.
Cited by (64)
Cyanobacteria-based microbial cell factories for production of industrial products
2021, Microbial Cell Factories Engineering for Production of BiomoleculesAntibacterial and antiviral metabolites from cyanobacteria: Their application and their impact on human health
2021, Current Research in BiotechnologyBioactive molecules from microalgae and constraints in commercialization
2020, Natural Bioactive Compounds: Technological AdvancementsCyanobacteria: Applications in Biotechnology
2018, Cyanobacteria: From Basic Science to ApplicationsAntibacterial, antifungal and antimycobacterial compounds from cyanobacteria
2017, Biomedicine and PharmacotherapyMicroseiramide from the freshwater cyanobacterium Microseira sp. UIC 10445
2015, Phytochemistry LettersCitation Excerpt :Compounds structurally related to lyngbyazothrins A–D have also been reported from strains that are morphologically similar to Lyngbya. These compounds include schizotrin A isolated from Schizotrix sp. (TAU strain IL-89-2) (Pergament and Carmeli, 1994), pahayokolides A and B isolated from a marine Lyngbya sp. (An et al., 2007), tychonamides A and B isolated from a Tychonema sp. (Mehner et al., 2008), and portoamides A–D isolated from Oscillatoria sp. LEGE 5292 (Leao et al., 2010).
Copyright © 1994 Published by Elsevier Ltd.